< Back to latest news & events

Awards

HGF Sets the Gold Standard – Recognised for 7th Year in a Row by Financial Times

June 2025

We are extremely honoured to announce that HGF has once again been ranked ‘Gold’ across all six bands in the Financial Times Special Report – Europe’s Leading Patent Law Firms 2025

This marks an extraordinary seventh consecutive year that HGF has been recognised since the guide’s inception in 2019. We are honoured to be one of only six firms to achieve gold across all categories, demonstrating our unwavering commitment to excellence in intellectual property. We would like to extend our heartfelt thanks to all the clients and industry professionals who have supported and voted for us.

More than 10,000 patent attorneys, both from law firms and corporate patent departments, were invited to participate in the survey. Participants were able to recommend firms overall and by specific specialities, divided into six categories. Having this recognition direct from our peers across the industry is an honour and highlights the value that they have placed on the expertise of HGF. The firm prides itself on the level of service and technical knowledge that the HGF team is able to provide to our global client base.

The firm was ranked ‘Gold – very frequently recommended for:’

  • Biotechnology, Food & Healthcare
  • Chemistry & Pharmacy
  • Electrical Engineering & Physics
  • Mechanical Engineering
  • IT & Software
  • Materials & Nanotechnology

Dr Andrew Wells, Head of the Chemistry team commented, “I’m delighted that our excellent reputation in the chemistry field has been recognised yet again. This is an excellent achievement for the HGF Chemistry team and for HGF as a whole. We have one of the largest teams of chemical and pharmaceutical patent attorneys based in Europe and we pride ourselves on providing commercially relevant and strategic IP advice to our clients. We cover the whole chemistry landscape and have seen significant growth in the key areas of pharmaceuticals, formulation science, materials science, agrochemicals, process chemistry, fuel cells, and electrochemistry. We also have a significant European oppositions practice that continues to go from strength to strength.”

Dr Chris Benson, Head of the Technology & Engineering team commented, “Achieving Gold status across all categories in the Financial Times: Europe’s Leading Patent Law Firms ranking is a prestigious honour. It reflects not only our firm’s deep expertise but also the outstanding dedication and innovation of the attorneys in our Technology and Engineering Group. This recognition places us among the best in our field throughout Europe and is something that we are very proud of.”

Kate Taylor, Head of the Life Sciences team commented: “Earning the Gold Award is an outstanding recognition, and it speaks volumes about the exceptional expertise and dedication of our Life Sciences Team. This achievement is a direct reflection of the passion, innovation, and deep knowledge each team member brings to the field.”

Martyn Fish, CEO commented: “This is an exciting time for HGF as we continue to innovate and set new standards in our industry. I am incredibly proud of everyone’s efforts and dedication that have made this achievement possible. This recognition is particularly meaningful as it is voted for by our clients and industry professionals, highlighting the trust and value they place in our teams.”

As a leading European intellectual property firm, we are committed to building strong, collaborative relationships with our clients and delivering exceptional service across our offices in Germany, the Netherlands, Switzerland, Austria, France, Ireland, and the UK.

Our multidisciplinary teams—including patent attorneys, trade mark attorneys, and IP solicitors—are united by our core values: People, Teamwork, Excellence, and Progressiveness.

At HGF, we strive to provide the highest standard of IP services. These prestigious recognitions are a testament to the dedication, expertise, and hard work of our talented team. We are proud of these accomplishments and remain focused on driving innovation and excellence across the IP landscape

To read the full report please click the button below.

 

Latest updates

Event - 23rd September 2025

Upcoming Webinar: Strategies for engaging with the EPO and JPO to get the Examiner on your side

Date: 20th October 2025 Time: 4.30 PM EDT | 1.30 PM PDT HGF and SHIGA are hosting an exclusive webinar exploring effective strategies for engaging with patent examiners at the European Patent …

Event details

Fashionably IP Podcast – Episodes 41-50 – exploring hot topics in the world of fashion and intellectual property

Episodes 41-50 of the Fashionably IP Podcast where we will be looking at important hot topics in the world of fashion and intellectual property. We will be focusing on key …

Read article

Agritech Thymes: A review of protection for gene edited plants

As we head into a new season, it’s a good time to revisit the current status of protection for Essentially Derived Varieties (EDVs) and plants derived from New Genomic Techniques …

Read article

Avoiding Legal Pitfalls: The Notting Hill Bag Company's Costly Mistake

[2025] EWHC 1793 (IPEC) – Natasha Courtenay-Smith and Notting Hill Bag Company Limited v The Notting Hill Shopping Bag Company Limited, Nangialai Takanai, The Notting Hill Shopper Bag Ltd, Ehsanullah …

Read article
Event - 12th September 2025

Wolters Kluwer Breakfast Panel on AI & IP at AIPPI

Sofie McPherson, Patent Director at HGF, will be moderating a special breakfast panel session hosted by Wolters Kluwer at the AIPPI World Congress in Yokohama on 15 September 2025. Session …

Event details

T1465/23 – No Narrowing by Description—EPO Board Terminates Inventive Step Analysis for Arbitrary Modifications Citing G1/24 and G1/19

“The potential patentability of a specific narrow embodiment…cannot render a claim allowable which, due to its breadth, encompasses a multitude of other, non-inventive embodiments” – r. 3.5. Background EP3113515 was …

Read article

Wrestling with G1/24 – How should the claims be interpreted in view of the description?

In G1/24, the Enlarged Board of Appeal (EBA) codified how claims should be interpreted for assessing patentability: in consultation with the description. However, the decision was light on how, in …

Read article

Welcome to HGF Presents - New Video Series

Introducing HGF Presents a new video series delivering practical insights into European Patent Law and practice. Curated by our leading experts in chemistry, life sciences, technology & engineering, each concise …

Read article